Back to Search
Start Over
Supplemental Figure 1 from Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Study design.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....23dd8e9480d35503f1208117f9fa8b6f
- Full Text :
- https://doi.org/10.1158/1078-0432.22467150.v1